Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2025 Rank: 67374
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1887 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67374 | 76934 |
| Total Cites | 9527 | 10475 |
| H-index | 56 | 58 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 215 | 216 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1148 | 1154 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 2462 | 2514 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7897 | 8303 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
9.05%
|
|
Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2024 Rank: 62292
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1790 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62292 | 71448 |
| Total Cites | 9288 | 10228 |
| H-index | 56 | 58 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 213 | 214 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1129 | 1135 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 2412 | 2464 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7681 | 8084 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
9.19%
|
|
Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2023 Rank: 57974
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1708 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57974 | 65968 |
| Total Cites | 9052 | 9983 |
| H-index | 55 | 58 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 212 | 213 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1120 | 1126 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 2375 | 2426 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7468 | 7866 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
9.33%
|
|
Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2022 Rank: 53393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1633 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53393 | 61300 |
| Total Cites | 8766 | 9689 |
| H-index | 54 | 56 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 210 | 211 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1104 | 1110 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 2328 | 2376 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7214 | 7610 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.27 |
| Self-Citation Percentage |
9.53%
|
|
Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2021 Rank: 52159
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1597 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52159 | 58996 |
| Total Cites | 8531 | 9434 |
| H-index | 53 | 55 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 207 | 208 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1070 | 1075 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 2264 | 2309 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7035 | 7425 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
9.57%
|
|
Payan, Donald G.
Rigel Pharmaceuticals Inc.,
United States
2020 Rank: 46878
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 1783 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46878 | 52780 |
| Total Cites | 8224 | 9113 |
| H-index | 52 | 55 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 204 | 205 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1059 | 1064 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 2218 | 2263 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6746 | 7126 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
9.76%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.